Testosterone Therapy

Testosterone Therapy for Obesity, Type 2 Diabetes, and Hypogonadism

A recent study presented at the European and International Congress on Obesity, Farid Saad, DVM, PhD, andrology and endocrinology specialist, shows long-term testosterone therapy had a substantial impact on weight loss and metabolic parameters in men with Hypogonadism (low testosterone) combined with obesity.

The study followed men with low testosterone and obesity over a period of 11 years.  Men who participated in testosterone therapy lost an average of 51 pounds, compared to an average gain of 13 pounds in men who did not take testosterone.  There was also evidence of the loss of visceral fat in the men who participated in testosterone therapy, with an average decreased waist circumference of 5 inches!  Men without testosterone increased their waist circumference by an average of 2.7 inches. The study also found that 22% of men who had Type 2 Diabetes achieved remission with testosterone therapy.

Saad stated “The weight loss surprised us most. When we started out, we didn’t really realize the potential effects because the weight loss was so subtle. The effects first became apparent at 4 years, and now we are pleased to see this weight loss has been sustained.”  He added that patients who endure typical weight loss programs usually regain the weight, but they didn’t see this with testosterone therapy patients.

Commenting on this study, Geoffrey Hackett, MD, a consultant in urology and sexual health at University Hospitals Birmingham Foundation Trust, UK, stated there are other studies supporting the findings of Dr. Saad’s study.  He confirmed that other studies showed loss of visceral fat and an increase in muscle mass with testosterone therapy. Gackett was involved in a similar study that followed 200 obese men with Type 2 Diabetes over a period of 4 years.  The study only found moderate weight loss but showed a decrease in waist circumference (loss of visceral fat) and other aspects of improved health. Another study conducted in Australia and recently presented to the American Diabetes Association showed a 40% reduction in the progression of Type 2 Diabetes with testosterone treatment.  Hackett added, “Unfortunately, diabetes and obesity specialists have chosen to ignore these data and persist with lifestyle interventions as the sole basis of management despite clear evidence that they are losing the battle.”

If you suffer from Type 2 Diabetes, obesity, low testosterone, or any combination of these, contact Edge today at 832-789-4989 and get your life back!

Sources: Testosterone: An Option for Weight Loss in Obesity With Hypogonadism – Medscape – Sep 08, 2020.

    Comments are closed